Literature DB >> 32800791

Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association.

Ileana L Piña1, Katherine E Di Palo2, Marie T Brown3, Niteesh K Choudhry4, Jamie Cvengros3, Deborah Whalen5, Laurie P Whitsel6, Janay Johnson6.   

Abstract

Medications do not work in patients who do not take them. This true statement highlights the importance of medication adherence. Providers are often frustrated by the lack of consistent medication adherence in the patients they care for. Today with the time constraints that providers face, it becomes difficult to discover the extent of non-adherence. There are certainly many challenges in medication adherence not only at the patient-provider level but also within a healthy system and finally in insurers and payment systems. In a cross-sectional survey of unintentional nonadherence in over 24,000 adults with chronic illness, including hypertension, diabetes and hyperlipidemia, 62% forgot to take medications and 37% had run out of their medications within a year. These sobering data necessitate immediate policy and systems solutions to support patients in adherence. Medication adherence for cardiovascular diseases (CVD) has the potential to change outcomes, such as blood pressure control and subsequent events. The American Heart Association (AHA)/American Stroke Association (ASA) has a goal of improving medication adherence in CVD and stroke prevention and treatment. This paper will explore medication adherence with all its inherent issues and suggest policy and structural changes that must happen in order to transform medication adherence levels in the U.S. and achieve the AHA/ASA's health impact goals.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adherence; American Heart Association; Barriers; Hypertension medications; Policy

Mesh:

Year:  2020        PMID: 32800791     DOI: 10.1016/j.pcad.2020.08.003

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  9 in total

1.  Medication Adherence in Chronic Older Patients: An Italian Observational Study Using Medication Adherence Report Scale (MARS-5I).

Authors:  Gloria Liquori; Aurora De Leo; Emanuele Di Simone; Sara Dionisi; Noemi Giannetta; Elvira Ganci; Sherly Pia Trainito; Giovanni Battista Orsi; Marco Di Muzio; Christian Napoli
Journal:  Int J Environ Res Public Health       Date:  2022-04-25       Impact factor: 4.614

Review 2.  Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease.

Authors:  Verughese Jacob; Jeffrey A Reynolds; Sajal K Chattopadhyay; David P Hopkins; Nicole L Therrien; Christopher D Jones; Jeffrey M Durthaler; Kimberly J Rask; Alison E Cuellar; John M Clymer; Thomas E Kottke
Journal:  Am J Prev Med       Date:  2021-12-04       Impact factor: 5.043

Review 3.  Posthospitalization Follow-Up of Patients With Heart Failure Using eHealth Solutions: Restricted Systematic Review.

Authors:  Ingvild Margreta Morken; Marianne Storm; Jon Arne Søreide; Kristin Hjorthaug Urstad; Bjørg Karlsen; Anne Marie Lunde Husebø
Journal:  J Med Internet Res       Date:  2022-02-15       Impact factor: 7.076

4.  Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy.

Authors:  Luca Degli Esposti; Chiara Veronesi; Domenica Daniela Ancona; Margherita Andretta; Fausto Bartolini; Alberto Drei; Alessandro Lupi; Stefano Palcic; Davide Re; Francesca Vittoria Rizzi; Elisa Giacomini; Valentina Perrone
Journal:  Clinicoecon Outcomes Res       Date:  2022-03-10

5.  Persistence of drug therapy is associated with ischemic stroke and other vascular events in high-risk stroke population.

Authors:  Xingyang Yi; Hong Chen; Ming Yu; Hua Luo; Ju Zhou; Wei Wei; Yanfen Wang; Xiaorong Chen
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

6.  Income and antiplatelet adherence following percutaneous coronary intervention.

Authors:  Anna R LaRosa; Gretchen M Swabe; Jared W Magnani
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-06-16

7.  Long-Term Association between Intensive Medical Treatment and the Incidence of Cardiovascular Outcomes in Patients with Dyslipidemia: an Observational Study.

Authors:  Guilherme Renke; Débora Pinto Gapanowicz; Marcela Batista Pereira; Fernanda Mattos; Marcelo Ribeiro-Alves; Marcelo Assad; Annie Seixas Bello Moreira
Journal:  Cardiol Ther       Date:  2022-10-12

8.  Do We Need a Specific Guideline for Assessment and Improvement of Acromegaly Patients Adherence?

Authors:  Maria Kamusheva; Alexina Parvanova; Yanitsa Rusenova; Silvia Vandeva; Atanaska Elenkova
Journal:  Front Public Health       Date:  2021-07-14

9.  Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Stephen P Glasser; Mara Vitolins; Michael V Rocco; Carolyn Harmon Still; Stacey S Cofield; William E Haley; David Goff
Journal:  Am J Hypertens       Date:  2022-02-01       Impact factor: 2.689

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.